171 related articles for article (PubMed ID: 37045797)
1. A Japanese registry study and systematic review of particle therapy for renal cell carcinoma.
Ishikawa H; Arimura T; Maruo K; Kawamura H; Toyama S; Ogino T; Okimoto T; Murakami M; Sato Y; Nishioka K; Araya M; Ohba H; Umehara K; Aoyama H; Obara W; Azuma H; Tsuji H; Sakurai H
J Radiat Res; 2023 Jun; 64(Supplement_1):i41-i48. PubMed ID: 37045797
[TBL] [Abstract][Full Text] [Related]
2. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
[TBL] [Abstract][Full Text] [Related]
3. Proton Therapy for Primary Renal Cell Carcinoma: The First Nationwide Retrospective Study in Japan.
Fukumitsu N; Ishikawa H; Arimura T; Wada H; Okimoto T; Sato Y; Iwata H; Shimizu S; Sakurai H
In Vivo; 2020; 34(5):2883-2889. PubMed ID: 32871828
[TBL] [Abstract][Full Text] [Related]
4. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
[TBL] [Abstract][Full Text] [Related]
5. The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group.
Franzese C; Marvaso G; Francolini G; Borghetti P; Trodella LE; Sepulcri M; Matrone F; Nicosia L; Timon G; Ognibene L; Vinciguerra A; Alongi F; Bortolus R; Corti L; Ramella S; Magrini SM; Livi L; Jereczek-Fossa BA; Scorsetti M; Arcangeli S
Clin Exp Metastasis; 2021 Dec; 38(6):527-537. PubMed ID: 34748125
[TBL] [Abstract][Full Text] [Related]
6. Particle Beam Radiation Therapy for Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinuses.
Hu W; Hu J; Huang Q; Gao J; Yang J; Qiu X; Kong L; Lu JJ
Front Oncol; 2020; 10():572493. PubMed ID: 33102230
[No Abstract] [Full Text] [Related]
7. Particle beam therapy for pelvic recurrence of colorectal cancer: a registry data analysis in Japan and a systematic review.
Murayama S; Yamada S; Hiroshima Y; Takiyama H; Taguchi H; Kimoto T; Anzai M; Hagiwara Y; Yasui K; Mori K; Ishihara S; Ueno H; Shimizu S; Aoyama H; Tsuji H; Sakurai H
J Radiat Res; 2023 Jun; 64(Supplement_1):i25-i33. PubMed ID: 37117038
[TBL] [Abstract][Full Text] [Related]
8. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
Amini A; Altoos B; Bourlon MT; Bedrick E; Bhatia S; Kessler ER; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD
Pract Radiat Oncol; 2015; 5(6):e589-e596. PubMed ID: 26142027
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
Stinauer MA; Kavanagh BD; Schefter TE; Gonzalez R; Flaig T; Lewis K; Robinson W; Chidel M; Glode M; Raben D
Radiat Oncol; 2011 Apr; 6():34. PubMed ID: 21477295
[TBL] [Abstract][Full Text] [Related]
10. Clinical results of proton beam radiotherapy for inoperable stage III non-small cell lung cancer: a Japanese national registry study.
Tatebe H; Harada H; Mori K; Iwata H; Akimoto T; Murakami M; Waki T; Ogino T; Nakamura M; Taguchi H; Nakayama H; Satouchi M; Aoyama H
J Radiat Res; 2023 Jun; 64(Supplement_1):i8-i15. PubMed ID: 37137157
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of Japanese nationwide cohort data of particle beam therapy for pulmonary, liver and lymph node oligometastases: particle beam therapy versus high-precision X-ray radiotherapy.
Aibe N; Ogino H; Wakatsuki M; Fujikawa K; Teramukai S; Fukumitsu N; Shiba S; Yamamoto N; Nomoto A; Ono T; Oguri M; Yamaguchi H; Numajiri H; Shibuya K; Okazaki S; Miyasaka Y; Okonogi N; Murata K; Tatebe H; Motegi A; Okimoto T; Yoshino T; Mandai M; Katoh N; Tsuji H; Sakurai H
J Radiat Res; 2023 Jun; 64(Supplement_1):i69-i83. PubMed ID: 37053162
[TBL] [Abstract][Full Text] [Related]
13. Updated long-term outcomes after carbon-ion radiotherapy for primary renal cell carcinoma.
Kasuya G; Tsuji H; Nomiya T; Makishima H; Haruyama Y; Kobashi G; Ebner DK; Hayashi K; Omatsu T; Kishimoto R; Yasuda S; Igarashi T; Oya M; Akakura K; Suzuki H; Ichikawa T; Shimazaki J; Kamada T;
Cancer Sci; 2018 Sep; 109(9):2873-2880. PubMed ID: 29981249
[TBL] [Abstract][Full Text] [Related]
14. High control rates of proton- and carbon-ion-beam treatment with intensity-modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center.
Mattke M; Vogt K; Bougatf N; Welzel T; Oelmann-Avendano J; Hauswald H; Jensen A; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Debus J; Uhl M
Cancer; 2018 May; 124(9):2036-2044. PubMed ID: 29469932
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies.
Zaorsky NG; Lehrer EJ; Kothari G; Louie AV; Siva S
Eur Urol Oncol; 2019 Sep; 2(5):515-523. PubMed ID: 31302061
[TBL] [Abstract][Full Text] [Related]
16. Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience.
Nomiya T; Tsuji H; Hirasawa N; Kato H; Kamada T; Mizoe J; Kishi H; Kamura K; Wada H; Nemoto K; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):828-33. PubMed ID: 18374507
[TBL] [Abstract][Full Text] [Related]
17. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Correa RJM; Louie AV; Zaorsky NG; Lehrer EJ; Ellis R; Ponsky L; Kaplan I; Mahadevan A; Chu W; Swaminath A; Hannan R; Onishi H; Teh BS; Muacevic A; Lo SS; Staehler M; Siva S
Eur Urol Focus; 2019 Nov; 5(6):958-969. PubMed ID: 31248849
[TBL] [Abstract][Full Text] [Related]
18. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in esophagogastric cancer patients.
Yamaguchi H; Fukumitsu N; Numajiri H; Ogino H; Katoh N; Okimoto T; Suzuki M; Sakurai H
J Radiat Res; 2023 Nov; 64(6):926-932. PubMed ID: 37697668
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of particle therapy for inoperable stage II-III non-small cell lung cancer: a systematic review and meta-analysis.
Chen Y; Luo H; Liu R; Tan M; Wang Q; Wu X; Du T; Liu Z; Sun S; Zhang Q; Wang X
Radiat Oncol; 2023 May; 18(1):86. PubMed ID: 37217970
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy".
Hoerner-Rieber J; Duma M; Blanck O; Hildebrandt G; Wittig A; Lohaus F; Flentje M; Mantel F; Krempien R; Eble MJ; Kahl KH; Boda-Heggemann J; Rieken S; Guckenberger M
J Thorac Dis; 2017 Nov; 9(11):4512-4522. PubMed ID: 29268521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
